Key points are not available for this paper at this time.
Methicillin-resistant Staphylococcus aureus (MRSA) poses a serious threat to public health and can form biofilms to enhance its drug resistance. Caffeic acid phenethyl ester (CAPE), which is primarily extracted from propolis, possesses diverse biological activities. However, its effect on anti-MRSA biofilms and the relevant mechanisms have not been fully clarified. Therefore, this study explored the ability of CAPE to combat MRSA biofilms. The results showed that CAPE has significant antibiofilm activities against MRSA. The minimum inhibitory concentration (MIC) values of CAPE were 256 µg/mL for the MRSA strains ATCC 33591, CI2, and CI3. Crystal violet (CV) assay and XTT assays demonstrated that CAPE could inhibit the formation and consolidation of MRSA CI2 biofilms. Experiments on scanning electron microscopy (SEM), bacterial adhesion assays, and the levels of extracellular polysaccharides confirmed that CAPE can inhibit bacterial adhesion, as well as the synthesis of extracellular polysaccharides in MRSA CI2. Real-time quantitative PCR (RT-qPCR) experiments confirmed that CAPE can affect the expression of MRSA icaADBC, sarA, fnbAB, and clfAB genes. Therefore, the proposed antibiofilm mechanism of CAPE involves the downregulation of aforementioned genes, leading to reduced production of extracellular polysaccharides and adhesion-related proteins, thereby weakening MRSA adhesion and ultimately exerting an antibiofilm effect. In conclusion, these findings suggest CAPE is a promising candidate drug as an antimicrobial agent for managing and preventing biofilm-associated infections caused by MRSA.
Feng et al. (Wed,) studied this question.